Daniel Wambua

Daniel Wambua is a highly experienced Principal Associate Scientist currently working at Kelonia Therapeutics since August 2022. Previously, Daniel held the position of Principal Associate Scientist at Oncorus from August 2017 to August 2022, and also worked as a Senior Associate Scientist, Associate Scientist II, and Contract Research Associate during that time. Prior experience includes a role as Research Technologist at Massachusetts General Hospital, contributing to cancer immunotherapy projects, and as Research Technician II at the Ragon Institute of MGH, MIT, and Harvard, focusing on Human cytomegalovirus infection. Daniel earned a Master's degree in Biology from Harvard University and a Bachelor of Science degree in Biology from California State University San Marcos.